Jagsonpal Pharmaceuticals
₹233.35
+0.15%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.03.
- Comfortable interest cover: operating profit covers interest about 58 times.
- Return on equity is healthy at 17.3%.
- Return on capital employed is healthy at 22.7%.
- Net profit margin is 15%.
- Profit has compounded about 21% a year over five years.
- Pays a dividend (yield about 1.72%).
- Has paid a dividend in each of the last 5 years on record.
- Promoters hold a majority stake (69.06%).
!Watch-points
- Recent profit growth (10%) is slower than the five-year pace (21%).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
5.58
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreModerate
5 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 1,539 Cr
Current Price₹ 233.35
High / Low₹ 264.50 / 155.00
Stock P/E34.776455
Book Value₹ 41.20
Dividend Yield0%
ROCE22.70%
ROE17.30%
Face Value₹ 2.00
Debt to Equity0.03
PEG Ratio2.04
EV / EBITDA23.04
Industry PE35.70
P/B Ratio5.9227395
EPS₹ 6.43
Debt₹ 8 Cr
PAT Margin14.98%
Cash PAT₹ 52 Cr
ICR58.00
Promoter Holding69.06%
FII Holding2.30%
DII Holding0.62%
Public Holding28.04%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity